NCT02597400 Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM Status COMPLETED Phase PHASE1
NCT02597101 Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT02597049 A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02587741 Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens Status UNKNOWN Phase EARLY_PHASE1
NCT02586129 Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes Status COMPLETED Phase PHASE3
NCT02577315 Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions Status COMPLETED Phase PHASE1
NCT02571608 Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control Status WITHDRAWN Phase PHASE4
NCT02568488 The Effect of Metformin on Different Hormones in PCOS Patients Status COMPLETED Phase PHASE4
NCT02565862 A Drug-drug Interaction Study Between Daclatasvir and Metformin Status COMPLETED Phase PHASE1
NCT02562664 Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients Status COMPLETED Phase PHASE2
NCT02561130 Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga Status COMPLETED Phase PHASE4
NCT02552355 Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin Status COMPLETED Phase PHASE2
NCT02551874 A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin Status COMPLETED Phase PHASE3
NCT02546050 The Effect of Metformin on Composition of Human Gut Bacteria Status COMPLETED Phase PHASE1
NCT02535975 The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy Status UNKNOWN Phase NA
NCT02535299 Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment Status UNKNOWN Phase PHASE4
NCT02532855 A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838) Status COMPLETED Phase PHASE3